Junye Wang

1.5k total citations · 1 hit paper
36 papers, 464 citations indexed

About

Junye Wang is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Junye Wang has authored 36 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 12 papers in Oncology. Recurrent topics in Junye Wang's work include Esophageal Cancer Research and Treatment (12 papers), Cancer-related molecular mechanisms research (7 papers) and Gastric Cancer Management and Outcomes (7 papers). Junye Wang is often cited by papers focused on Esophageal Cancer Research and Treatment (12 papers), Cancer-related molecular mechanisms research (7 papers) and Gastric Cancer Management and Outcomes (7 papers). Junye Wang collaborates with scholars based in China, United States and South Korea. Junye Wang's co-authors include Shuqin Dai, Wanli Liu, Zi-Teng Zhang, Yuzhen Zheng, Yuehao Lin, Shaobo Liang, Xiaowei Liu, Wenyu Zhai, Fang Wang and Lei Han and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Junye Wang

33 papers receiving 459 citations

Hit Papers

Inhibition of NF-κB signaling unveils novel strategies to... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers
    2024 54 citations Yuanfang Li, Hailin Tang et al. Drug Resistance Updates profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junye Wang China 14 198 148 142 138 118 36 464
Junming Xu China 12 239 1.2× 97 0.7× 140 1.0× 74 0.5× 31 0.3× 27 402
Yuchao Dong China 11 177 0.9× 87 0.6× 88 0.6× 110 0.8× 66 0.6× 27 405
Yifang Zhu China 11 265 1.3× 177 1.2× 162 1.1× 231 1.7× 33 0.3× 24 540
Yingjie Li China 11 186 0.9× 122 0.8× 152 1.1× 166 1.2× 187 1.6× 17 560
Juanjuan Che China 13 273 1.4× 149 1.0× 136 1.0× 89 0.6× 63 0.5× 20 512
Chen‐Sung Lin Taiwan 12 246 1.2× 64 0.4× 105 0.7× 104 0.8× 77 0.7× 23 466
Jianyu Xu China 14 331 1.7× 103 0.7× 234 1.6× 78 0.6× 66 0.6× 33 515
Jingmei Su China 8 239 1.2× 187 1.3× 83 0.6× 52 0.4× 29 0.2× 11 402
Shouhui Yang United States 9 301 1.5× 240 1.6× 201 1.4× 98 0.7× 33 0.3× 14 543

Countries citing papers authored by Junye Wang

Since Specialization
Citations

This map shows the geographic impact of Junye Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junye Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junye Wang more than expected).

Fields of papers citing papers by Junye Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junye Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junye Wang. The network helps show where Junye Wang may publish in the future.

Co-authorship network of co-authors of Junye Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Junye Wang. A scholar is included among the top collaborators of Junye Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junye Wang. Junye Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gong, L., et al.. (2025). The role of ZC3H13 in promoting M2 macrophage infiltration via m6A methylation in esophageal squamous cell carcinoma tumor progression. Frontiers in Immunology. 16. 1612041–1612041. 1 indexed citations
2.
Gong, Li, et al.. (2024). Roles of long non‑coding RNAs in esophageal cell squamous carcinoma (Review). International Journal of Molecular Medicine. 54(2). 1 indexed citations
3.
Li, Yuanfang, Hailin Tang, Sicheng Wang, et al.. (2024). Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers. Drug Resistance Updates. 73. 101042–101042. 54 indexed citations breakdown →
4.
Zhai, Wenyu, Fangfang Duan, Yaobin Lin, et al.. (2023). Pan-Immune-Inflammatory Value in Patients with Non-Small-Cell Lung Cancer Undergoing Neoadjuvant Immunochemotherapy. Journal of Inflammation Research. Volume 16. 3329–3339. 13 indexed citations
5.
Yang, Yong, Zewei Zhang, Shiliang Liu, et al.. (2023). A Surrogate Endpoint for Overall Survival in Locally Advanced and Resectable Esophageal Squamous Cell Carcinoma: A Reanalysis of Data From the NEOCRTEC5010 Trial. International Journal of Radiation Oncology*Biology*Physics. 117(4). 809–820. 1 indexed citations
6.
7.
8.
Zhai, Wenyu, Fangfang Duan, Si Chen, et al.. (2022). An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Squamous Carcinoma. Frontiers in Cell and Developmental Biology. 10. 770550–770550. 15 indexed citations
9.
Zhai, Wenyu, Fangfang Duan, Si Chen, et al.. (2022). A Novel Inflammatory-Related Gene Signature Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma. Frontiers in Genetics. 12. 798131–798131. 15 indexed citations
10.
Zhai, Wenyu, Fangfang Duan, Li Gong, et al.. (2021). Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 769881–769881. 6 indexed citations
11.
Zhai, Wenyu, Yuzhen Zheng, Yuming Rong, et al.. (2021). The impact of an N1 lymph node examination in patients with early-stage non-small cell lung cancer: a retrospective cohort study. Journal of Thoracic Disease. 13(4). 2184–2193.
12.
Zheng, Yuzhen, Xiaoqiang Li, Junye Wang, et al.. (2020). Impact of examined lymph node count for oesophageal squamous cell carcinoma in patients who underwent left transthoracic oesophagectomy. European Journal of Surgical Oncology. 46(10). 1956–1962. 5 indexed citations
13.
Lai, Yanzhen, Xueping Wang, Tao Zeng, et al.. (2018). Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer. Journal of Cancer. 9(9). 1538–1547. 26 indexed citations
14.
Wang, Fang, et al.. (2018). LINC00460 modulates KDM2A to promote cell proliferation and migration by targeting miR-342-3p in gastric cancer. OncoTargets and Therapy. Volume 11. 6383–6394. 55 indexed citations
15.
Liu, Zifeng, Jin Liu, Shuang Li, et al.. (2018). High expression of tumor necrosis factor receptor 2 in tissue is associated with progression and prognosis of esophageal squamous cell carcinoma. Human Pathology. 80. 179–185. 8 indexed citations
16.
Zhang, Zi-Teng, et al.. (2017). Icariin exerts inhibitory effects on the growth and metastasis of KYSE70 human esophageal carcinoma cells via PI3K/AKT and STAT3 pathways. Environmental Toxicology and Pharmacology. 54. 7–13. 42 indexed citations
17.
Xie, Xuan, Hong Yang, Kongjia Luo, et al.. (2016). Resectable left lower lobe non–small cell lung cancer with lymph node metastasis is related to unfavorable outcomes. Chinese Journal of Cancer. 35(1). 7–7. 3 indexed citations
18.
Situ, Dongrong, Junye Wang, Peng Lin, et al.. (2013). Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma?. Journal of Thoracic and Cardiovascular Surgery. 146(1). 45–51. 20 indexed citations
19.
Wang, Junye, Yuzhen Zheng, Juan Yang, et al.. (2012). Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma. BMC Cancer. 12(1). 365–365. 37 indexed citations
20.
Ma, Guowei, Xu Zhang, Junye Wang, et al.. (2006). A study of molecular resection margins for esophageal squamous cell carcinoma using large pathologic sections. Chinese Journal of Clinical Oncology. 3(5). 315–321. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junming Xu Breakdown of academic impact, for papers by Yuchao Dong Breakdown of academic impact, for papers by Yifang Zhu Breakdown of academic impact, for papers by Yingjie Li Breakdown of academic impact, for papers by Juanjuan Che Breakdown of academic impact, for papers by Chen‐Sung Lin Breakdown of academic impact, for papers by Jianyu Xu Breakdown of academic impact, for papers by Jingmei Su Breakdown of academic impact, for papers by Shouhui Yang
Rankless by CCL
2026